1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,072 | 0,078 | 11:57 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SYNTHETICMR Aktie jetzt für 0€ handeln | |||||
| 27.05. | Report from Annual General Meeting in SyntheticMR AB (publ) | 1 | Cision News | ||
| 12.05. | SYNTHETICMR AB: Interim report January - March 2026 | 1 | Cision News | ||
| 21.04. | Notice to attend the Annual General Meeting of SyntheticMR AB (publ) | 4 | Cision News | ||
| 09.04. | SYNTHETICMR AB: SyntheticMR publishes Annual Report for 2025 | 1 | Cision News | ||
| 07.04. | Change of date for the Annual General Meeting in SyntheticMR AB (publ) | 1 | Cision News | ||
| 12.02. | Spotlight Stock Market: Market Notice 19/26 - Last day of trading in SyntheticMR AB's BTA | 1 | Cision News | ||
| 11.02. | SYNTHETICMR AB: SyntheticMR's rights issue has been registered - conversion of BTA into shares | 2 | Cision News | ||
| 06.02. | SYNTHETICMR AB: Year-End report January - December 2025 | 1 | Cision News | ||
| 04.02. | SYNTHETICMR AB: SyntheticMR publishes the outcome of the rights issue | 1 | Cision News | ||
| 20.01. | Today the subscription period commences in SyntheticMR AB's rights issue | 2 | Cision News | ||
| 19.01. | SyntheticMR AB publishes information document regarding the rights issue | 1 | Cision News | ||
| 19.01. | SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue | 1 | Cision News | ||
| 16.01. | SYNTHETICMR AB: Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR's Position with a Broader Neuroimaging Offering | 1 | Cision News | ||
| 15.01. | SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue | 1 | Cision News | ||
| 14.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.01.2026 | 562 | Xetra Newsboard | Das Instrument 9480 SE0015987946 SYNTHETICMR AB AK EQUITY wird cum Kapitalmassnahme gehandelt am 14.01.2026 und ex Kapitalmassnahme am 15.01.2026 The instrument 9480 SE0015987946 SYNTHETICMR AB AK EQUITY... ► Artikel lesen | |
| 09.01. | Spotlight Stock Market: Market Notice 5/26 - Information regarding the rights issue from SyntheticMR AB | 2 | Cision News | ||
| 09.01. | Report from the extraordinary general meeting in SyntheticMR AB (publ) | 2 | Cision News | ||
| 18.12.25 | Notice of extra general meeting in SyntheticMR AB (publ) | 1 | Cision News | ||
| 17.12.25 | SyntheticMR AB resolves on a fully secured rights issue of approximately SEK 32.8 million | 1 | Cision News |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,012 | -12,68 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| UNIDOC HEALTH | 0,059 | -1,66 % | UniDoc Health Corp.: UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase | AMD Telemedicine software and related systems now fully integrated; UniDoc Connect used at more than 800 sites across 48 countries VANCOUVER, BC / ACCESS Newswire / May 21, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,046 | +7,06 % | Mountain Valley MD Holdings Inc: Mountain Valley MD appoints advisers, grants options | ||
| LIGHT AI | 0,161 | +6,29 % | Light AI Inc: Light AI begins QuickScan Strep A clinical trial | ||
| IMAGIN MEDICAL | 0,001 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2026.ISIN NameCA2985962067 EUREKA... ► Artikel lesen | |
| AROVELLA THERAPEUTICS | 0,037 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: Notification of cessation of securities - ALA | ||
| PREVECEUTICAL MEDICAL | 0,012 | 0,00 % | PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors | Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical"), a health sciences company that develops innovative... ► Artikel lesen | |
| MEMPHASYS | 0,002 | 0,00 % | Memphasys inks maiden South-East Asian commercialisation agreement | ||
| HERAMED | 0,026 | 0,00 % | XFRA 1I4: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| THERMA BRIGHT | 0,028 | -22,22 % | Therma Bright Inc.: Therma Bright Announces Follow-On Order from Horizon Health as Venowave Gains Traction in U.S. Vascular Markets | Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced... ► Artikel lesen | |
| ARIKA RESOURCES | 0,012 | 0,00 % | Daily Special:Chilwa Minerals, Arika Resources, AuKing Mining | ||
| CARMAT | 0,049 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2026.ISIN NameCA4013392051 GUARDIAN... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,37 | -0,05 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| ALIGNMENT HEALTHCARE | 15,380 | +0,07 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| GENEDX | 52,26 | +0,10 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more |
Das Unternehmen SYNTHETICMR AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,55 % bei einem Aktienkurs von 0,042 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SYNTHETICMR AB finden Sie auf Wallstreet Online.